Trulieve Cannabis Corp. (NYSE: TRLV)
Health Care · Pharmaceuticals · US
$11.32
+1.62% today · +30.3% 1Y
Trulieve Cannabis Corp. (NYSE: TRLV) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $2.18B and employs 5,000 people.
Over the last twelve months the share price has gained 30.3%, trading between 4.62 and 13.28.
Tweenvest scores Trulieve Cannabis Corp. across four factors: quality 60/100, value 26/100, growth 52/100. Its strongest factor is quality.
TRLV price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $2.18B
- Revenue (TTM)
- $1.14B
- P/E
- —
- EPS
- -2.46
- Dividend yield
- —
- Beta (5Y)
- 1.72
- 52-week high
- $13.28
- 52-week low
- $4.62
- Avg volume (3M)
- —
- Shares outstanding
- 192.57M
- Employees
- 5,000
- Next earnings
- —
About Trulieve Cannabis Corp.
Trulieve Cannabis Corp. engages in the cultivation, processing, manufacturing, and retail distribution of medical and adult-use cannabis products. It cultivates and produces its products in-house and distributes to its branded stores, as well as directly to patients via home delivery. The company was founded by Kim Rivers & Jason Pernell on September 17, 1940 and is headquartered in Tallahassee, FL.
- ISIN
- US89790E1064
- Founded
- 1940
- Listed since
- Sep 25, 2018
- Exchange
- New York Stock Exchange
- Currency
- USD
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.10T | $1,233.66 | -1.06% |
| Johnson & JohnsonNYSE: JNJ | $658.24B | $273.14 | +0.04% |
| Merck & Co., Inc.NYSE: MRK | $385.99B | $156.45 | +3.84% |
| Roche Holding AGSWX: ROP | $371.62B | CHF373.80 | +0.92% |
| Novartis AGSWX: NOVN | $303.81B | CHF128.34 | +1.25% |
| AstraZeneca PLCLSE: AZN | $263.84B | £124.76 | +3.02% |
| Novo Nordisk A/SCPSE: NOVO B | $212.51B | Dkr307.80 | +2.86% |
| Pfizer Inc.NYSE: PFE | $162.84B | $28.57 | +2.15% |
Figures last refreshed Aug 18, 2026.